Progenitor Cell Therapy

Minaris is a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) that specializes in providing advanced therapies and biosafety testing services for biologics, monoclonal antibodies, vaccines, and cell and gene therapy developers. With over 25 years of experience in cell therapy and more than 40 years in analytical and... biosafety testing, Minaris offers comprehensive services including process development, cGMP manufacturing, and advanced testing. Their global footprint includes state-of-the-art facilities across the U.S., Europe, and Asia, ensuring high-quality standards and regulatory compliance. Minaris aims to support innovators in bringing life-changing therapies to patients by streamlining the development and commercialization processes.Read More